Radionuclide Therapy:Astatin・Others 2

[M2B6C1] Biodistribution and safety evaluation of alpha-emitting ²¹¹At-MABG in normal mice

Keiichiro Yoshinaga¹, Hitomi Sudo², Aya Sugyo², Atsushi Tsuji², Katsuyuki Minegishi², Kotaro Nagatsu², Noriko Ishioka³, Tatsuya Higashi² (1.Diagnostic and Therapeutic Nuclear Medicine, National Institute of Radiological Sciences, 2.National Institutes for Quantum and Radiological Science and Technology, National Institute of Radiological Sciences, Chiba, Japan, 3.National Institutes for Quantum and Radiological Science and Technology, Takasaki, Japan)